HORAK IVAN D 4
4 · ENZON PHARMACEUTICALS INC · Filed Nov 24, 2010
Insider Transaction Report
Form 4
HORAK IVAN D
EVP, R&D, Chief Scientific Off
Transactions
- Exercise/Conversion
Common Stock
2010-11-23+3,000→ 138,188 total - Tax Payment
Common Stock
2010-11-23$10.92/sh−1,063$11,608→ 137,125 total - Exercise/Conversion
Restricted Stock Units
2010-11-23−3,000→ 0 totalExercise: $0.00From: 2010-11-23Exp: 2010-11-23→ Common Stock (3,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock.
- [F2]Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock units described in this Form 4.